[account_shop_links]
Forest Labs Clinical Development Profile
$700.00 – $1,400.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
ISR’s report provides a thorough analysis of Forest Laboratories’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Forest’s key products.
What you will learn:
- Drug sales and company financial condition over the past four years
- Number, length, and patient enrollment of clinical trials segmented by phase and trial type
- Current R&D pipeline overview
- Important aspects of Forest’s key products such as MOA, dosing, and interaction characteristics
How you can use this report:
- Pharmaceutical Companies: Identify the clinical and commercial status of competing compounds and understand how these will affect the launch of similar products.
- For Service Providers: Learn Forest’s strategic direction and better understand their clinical development pipeline.
Methodology:
Data have been compiled through an exhaustive secondary research effort. ISR has utilized company websites, annual reports, clinicaltrials.gov, and government filings along with additional sources to provide clinical trial and key product data.
